ID 416313493 · FY 2017–2024 · 8 years
ARTPHARMA — a Tbilisi-based pharmaceutical importer, distributor and brand representative ("we create health", artpharma.ge), partnering with international principals such as Walmark, New Nordic and STADA. Its portfolio is weighted to OTC products, food supplements and dermocosmetics (Vitrum, Vitaferol, Proenzi, Arthrostop, Martians, Omega-3 Premium, New Nordic, Neutraderm), which explains its high gross margin. Office: Tbilisi, Lvovi St. 92.
curated 2026-06-25
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,281 | 2,905 | 3,312 | 5,194 | 7,486 | 6,232 | 5,659 | 6,223 | +15.4% |
| Total COGS | -992 | -1,310 | -1,308 | -2,123 | -4,437 | -2,762 | -2,272 | -2,798 | +16.0% |
| Gross Profit | 1,288 | 1,595 | 2,004 | 3,071 | 3,049 | 3,470 | 3,387 | 3,425 | +15.0% |
| Gross Margin | 56.5% | 54.9% | 60.5% | 59.1% | 40.7% | 55.7% | 59.8% | 55.0% | |
| Total Operating Expenses | -876 | -894 | -1,246 | -1,331 | -1,254 | -1,516 | -1,300 | -1,470 | +7.7% |
| EBITDA | 413 | 701 | 758 | 1,740 | 1,795 | 1,954 | 2,087 | 1,954 | +24.9% |
| EBITDA Margin | 18.1% | 24.1% | 22.9% | 33.5% | 24.0% | 31.3% | 36.9% | 31.4% | |
| Total D&A | -28 | -41 | -45 | -38 | -34 | -29 | -16 | -42 | +5.9% |
| EBIT / Operating Income | 385 | 661 | 713 | 1,702 | 1,761 | 1,925 | 2,071 | 1,913 | +25.7% |
| Total Interest Income | 0 | 0 | 0 | 0 | 0 | 6 | 22 | 22 | +95.0% |
| Total Interest Expense | 0 | -101 | -82 | -72 | -6 | -21 | -16 | -19 | -24.2% |
| Total Other Income | -3 | -23 | -1 | -7 | 3 | -14 | -2 | 2 | nmf |
| Profit Before Tax | 382 | 537 | 630 | 1,623 | 1,759 | 1,895 | 2,075 | 1,917 | +25.9% |
| Total Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Net Profit / (Loss) | 413 | 678 | 757 | 1,733 | 1,798 | 1,940 | 2,085 | 1,956 | +24.9% |
| Net Margin | 18.1% | 23.4% | 22.9% | 33.4% | 24.0% | 31.1% | 36.8% | 31.4% |
Ownership & directors from companyinfo.ge (public corporate registry).